IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Early stage biotech developing immune cell therapies for cancer.
Industry: Health Care
Latest Trade: $10.38 -0.22 (-2.1%)
First Day Return: +32.2%
Return from IPO: -97.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/26/2021 |
Offer Price | $20.00 |
Price Range $19.00 - $20.00 | |
Offer Shares (mm) | 16.0 |
Deal Size ($mm) | $320 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/18/2021 |
Offer Price | $20.00 |
Price Range $19.00 - $20.00 | |
Offer Shares (mm) | 16.0 |
Deal Size ($mm) | $320 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Morgan Stanley |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Dallas, TX, United States |
Founded | 2018 |
Employees | 150 |
Website instilbio.com |